Original Research
Accepted on 03 Mar 2026
A selective agonist of the prostacyclin (IP) receptor alleviates microglial and astroglial neuroinflammatory responses through P38 and NLRP3
in Inflammation
Original Research
Accepted on 03 Mar 2026
in Inflammation
Hypothesis and Theory
Accepted on 03 Mar 2026
in Higher Education
Review
Accepted on 03 Mar 2026
in Inflammation
Review
Accepted on 03 Mar 2026
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 03 Mar 2026
in Climate and Decision Making
Correction
Accepted on 03 Mar 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 03 Mar 2026
in Stroke
Original Research
Accepted on 03 Mar 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 03 Mar 2026
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 03 Mar 2026
in Stem Cell Research
Original Research
Accepted on 03 Mar 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 03 Mar 2026
in Cognition
Original Research
Accepted on 03 Mar 2026
in Cognition
Original Research
Accepted on 03 Mar 2026
in Clinical Research and Treatment in Lupus
Original Research
Accepted on 03 Mar 2026
in Agricultural and Food Economics
Original Research
Accepted on 03 Mar 2026
in Animal Nutrition and Metabolism